Biopharma

Opinion: Bird flu is spreading. Wastewater monitoring c...

The National Wastewater Surveillance System’s funding expires at the end of fisc...

‘Polio, bad’: Bill Nye the Science Guy rebukes RFK Jr. ...

Bill Nye critiqued HHS chief Robert F. Kennedy Jr. and his views on science and ...

‘We’re living in the Twilight Zone’: Researchers decry ...

At the STAT Summit on Thursday, researchers called for a "full-throated defense"...

Why a weight-loss drug could become a geopolitical barg...

Ozempic might feature in future US negotiations with Denmark over Greenland

Former UK IPO star Nanopore admits it is a takeover target

DNA sequencing specialist’s decision to list in London in 2021 was seen as a vic...

Women in UK face HRT treatment ‘lottery’, doctors warn

Experts say there are regional disparities in medication access even as prescrip...

PEP-Therapy Receives FDA Orphan Drug Designation for PE...

Paris (France), March 17, 2025 – PEP-Therapy, a clinical-stage biotechnology com...

Azer-cel Granted FDA Fast Track Designation in Blood Ca...

SYDNEY, Australia, 19 March 2025: Imugene Limited (ASX:IMU), a clinical-stage im...

J&J advances Stelara succession scheme with key FDA nod...

The FDA approved Tremfya as an induction therapy in adults with moderately to se...

Novartis plans 427 layoffs as looming Entresto patent c...

Novartis is laying off 427 employees who report to its headquarters in East Hano...

Alnylam's Amvuttra wins key approval in ATTR-CM, teeing...

Despite growing competition in the transthyretin amyloid cardiomyopathy (ATTR-CM...

FDA Announces 'Operation Stork Speed' to Improve Infant...

THURSDAY, March 20, 2025 -- In an effort to guarantee "the ongoing quality, saf...

Total Injury Death Rate Increased From 2013 to 2021, Fo...

THURSDAY, March 20, 2025 -- The total injury death rate in the United States in...

Increasing Sleepiness Linked to Dementia Risk in Oldest...

THURSDAY, March 20, 2025 -- Increasing sleepiness is associated with increased ...

STAT+: Pfizer’s Wall Street critic-turned-executive dig...

Andrew Baum, Pfizer's chief strategy and innovation officer, talked Thursday abo...

STAT+: Alnylam drug wins FDA approval for progressive h...

The FDA cleared Alnylam’s therapy for the heart disease ATTR-CM, setting the com...

Alnylam drug gets long-awaited FDA approval in deadly h...

Amvuttra’s clearance in a rare form of cardiomyopathy could help Alnylam turn a ...

STAT+: We employ you, we employ you not: Fired probatio...

“It’s like we're in a toxic relationship with our employer”: Fired probationary ...

Former FDA commissioner Scott Gottlieb questions RFK Jr...

Trump's former FDA commissioner criticized the current administration's approach...

Zealand’s obesity strategy and Immunovant’s curious dev...

This week on "The Readout LOUD" podcast: Zealand's obesity strategy, Immunovant'...

STAT+: A new biotech licensing Chinese drugs with a uni...

Expedition Therapeutics, a new startup hoping to source the best therapies being...

Lilly backs study in mission to improve Hollywood repre...

Hollywood has in recent years been undergoing a much-needed, long-awaited transf...

Calling UK 'uninvestable,' pharma giants demand revamp ...

Global pharma giants AstraZeneca, Bristol Myers Squibb, Johnson & Johnson, Novar...

BioNTech passes on Autolus' CD19/CD22 CAR-T amid pipeli...

BioNTech has passed on Autolus Therapeutics’ dual targeting CAR-T cell therapy. ...

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.